Surveillance of antibiotic resistance in the northern zone of Senegal: Molecular characterization of beta-lactam resistance genes in Enterobacteriaceae (extended spectrum beta-lactamase, plasmid cephalosporinases, carbapenemases).
DOI:
https://doi.org/10.14738/bjhmr.101.13642Keywords:
Surveillance, ESBL, Molecular characterization, Northern SenegalAbstract
Introduction: With the increase in bacterial resistance to antibiotics, policies are being implemented on a national scale. These resistances are multiple, especially in enterobacteria, and represent a real public health problem due to the difficulty of their treatment. The objective of this work was to identify ESBL, cephalosporinase and carbapenemase producing enterobacteria in laboratories in the northern part of Senegal and to compare the mechanisms involved. Materials and methods: This is a retrospective study conducted at the Saint-Louis Regional Hospital and the Microbiology Unit of the Pasteur Institute of Dakar. Bacterial strains were collected between January and June 2021 in eight bacteriology laboratories in the regions of Saint-Louis, Louga and Matam. Bacterial identification was done by studying morphological, cultural and biochemical characteristics using an API® 20 E gallery and the MALDI-TOFF technique. The antibiogram was performed by the disc diffusion method according to the CA-SFM version 2021 procedure including the search for specific resistances (ESBL). The ESBL genes (CTX, TEM, OXA, and SHV) were identified by polymerase chain reaction (PCR) with specific primers and then analyzed by gel electrophoresis. Results: Forty-five strains of Enterobacteriaceae were ESBL producers and each had at least one beta-lactam resistance gene. The CTX-M gene was found in all strains, followed by the OXA (64.44%), TEM (53.33%) and SHV (20%) genes. A simultaneous presence of these 4 genes was noted in 6 isolates (13.33%). Apart from resistance to ertapenem, all strains were sensitive to imipenem. For quinolones, almost all strains (93%) were resistant. Conclusion: These results show the need to reinforce the surveillance of ESBL-producing Enterobacteriaceae in the Senegal area. These important data should help to orientate strategies for the reduction of MRBs and their dissemination in the community.
References
Dublanchet A. What is phage therapy. Hegel. 2014; 4 (4):354-370. 46 G. C. (2023). Surveillance of antibiotic resistance in the northern zone of Senegal: Molecular characterization of beta-lactam resistance genes in
Stahl JP. Epidemiology, control and treatment of antibiotic resistance: proceedings of the 45th ICAAC Congress, Washington 2005. Medicine and Infectious Diseases. 2006; 36(5):290-296.
Nordmann P, Demord A, Poirel L, D'Emedio F, Pomponio S. Rapid detection of extended-spectrum ß-lactamase-producing enterobacteria. Medicine and Infectious Diseases. 2019; 49(4):47.
Teklu DS, Negeri AA, Legese M H. et al. Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia. Antimicrob Resist Infect Control. 2019; 8(39).
Ravat F, Jault P, Gabard J. Bacteriophages and phage therapy: using natural viruses to treat bacterial infections. Ann Burns Fire Disasters. 2015; 31; 28(1):13-20.
Clouzeau B, Boyer A, M'Zali F, et al. New therapeutic strategies against extended-spectrum β-lactamaseproducing enterobacteria. Resuscitation. 2015; 24: 270-277.
Courvalin P. Antimicrobial drug resistance: ‘‘Prediction is very difficult, especially about the future ’’. Emerg. Infect. Dis., 2005; 11:1503-1506.
Lahlaoui H, Haj Khalifa AB, Ben Moussa M. Epidemiology of CTX-M extended-spectrum β-lactamase (ESBL)-producing enterobacteria. Medicine and Infectious Diseases. 2014; 44(9): 400-404.
Diagne R. Research of ESBL genes of type TEM, SHV, and OXA-1 on E. coli strains isolated at the Bacteriology laboratory of Fann, Senegal. RAMReS Health Sciences. 2018; 1(1):1-5.
Mennane Z, Aicha Q, Sahraoui HL, Halout K, Hamamouchi J, Khedid K, Bahbah R, Bourchid M, Baghdadi N, and Charof R. Phenotypic and genotypic profile of isolated hospital-enterobacteria from four Moroccan hospitals during 2011 and 2012. International Journal of Innovation and Applied Studies. 2016; 15(1): 55–60.
El bouamri MC, Arsalane L, Zerouali K, Katfy K, El kamouni Y, Zouhair S. Molecular characterization of extended spectrum β-lactamase-producing Escherichia coli in a university hospital in Morocco, North Africa. African Journal of Urology. 2015; 21(3):161-166.
Dia ML, Ngom B, Diagne R ET col. Molecular detection of CTX-M-15-type β-lactamases in Escherichia coli strains from Senegal. New Microbes and New Infections. 2016; 9:45-46.
Olley M, Maureen UO et col. Distribution of TEM, SHV, OXA AND CTX-M Genes among ESBLproducing E. coli isolates from patients with urinary tract infections. Sokoto Journal of Medical Laboratory Science. 2020; 5(1):1-10.
Naas T, Poirel L, Nordmann P. Minor extended-spectrum β-lactamases. Clinical Microbiology and Infection. 2008; 14(1):42-52.
Ruppé E. Epidemiology of extended spectrum beta-lactamases: the advent of CTX-M. Antibiotics. 2010; 12(1): 3-16.
Abid F, Nafissa B, Mazouz D, et al. Extended-spectrum beta-lactamase (ESBL)-producing Klebsiella Pneumoniae isolated from hospitals in the city of Annaba, Algeria. Sci Study Res. 2007; 8 (2):199-214.
Anago E, Ayi-Fanou, Akpovi CD, Hounkpe WB and col. Antibiotic resistance and genotype of beta-lactamase producing Escherichia coli in nosocomial infections in Cotonou, Benin. Ann Clin Microbiol Antimicrob. 2015 ; 14: 5
Ugbo EN, Anyamene CO ET col. Prevalence of blaTEM, blaSHV, and blaCTX-M genes among extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae of clinical origin. Gene Reports. 2020; 21. 29. Mehdi RM, Javid T. Prevalence of Extended-spectrum Beta-lactamase (ESBL) Types blaTEM and blaSHV in Klebsiella pneumonia Strains isolated from Clinacal Samples by PCR in Miandoad, West Azarbaijan. Iran Journal of Medical Microbiology. 2021; 15(4): 458-464.
Kamal IB ET col. Molecular detection of β-lactamase genes in Klebsiella pneumoniae and Escherichia coli isolated from different clinical sources. Cellular and Molecular Biology. 2022; 67(4): 170-180.
EL Bouamri MC, Arsalane L, Kamouni Y, Berraha M, Zouhair S. Recent evolution of the epidemiological profile of extended-spectrum β-lactamase producing uropathogenic enterobacteria in Marrakech, Morocco. Prog Urol. 2014; 24(7) :451-5.
Sbiti M, Lahmadi K, Louzi L. Epidemiological profile of extended-spectrum beta-lactamase-producing uropathogenic enterobacteria. Pan African Medical Journal. 2017; 28(1).
Leotard S, Negrin N. Epidemiology of Enterobacteriaceae producing extended-spectrum beta-lactamase in GRASSE hospital (2005–2008). Pathologie biologie. 2010; 58(1): 35-38.
Sire JM, Nabeth P, et col. Antimicrobial Resistance in Out patients Escherichia coli Urinary Isolates in Dakar, Senegal. The Journal of Infection in developing Countries. 2007; 1(3):1-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Amadou KANE
This work is licensed under a Creative Commons Attribution 4.0 International License.
